Zoetis Inc. (ZTS): Price and Financial Metrics

Zoetis Inc. (ZTS): $164.18

2.94 (+1.82%)

POWR Rating

Component Grades














  • ZTS scores best on the Quality dimension, with a Quality rank ahead of 94.57% of US stocks.
  • The strongest trend for ZTS is in Growth, which has been heading down over the past 179 days.
  • ZTS ranks lowest in Momentum; there it ranks in the 15th percentile.

ZTS Stock Summary

  • ZTS has a higher market value than 97.24% of US stocks; more precisely, its current market capitalization is $74,781,348,228.
  • ZTS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 582.07 -- higher than 95.09% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for ZTS is currently 39.11, higher than 89.01% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to ZOETIS INC, a group of peers worth examining would be BSX, ABB, BDX, SYK, and A.
  • ZTS's SEC filings can be seen here. And to visit ZOETIS INC's official web site, go to www.zoetis.com.

ZTS Valuation Summary

  • In comparison to the median Healthcare stock, ZTS's EV/EBIT ratio is 327.48% higher, now standing at 28.
  • ZTS's EV/EBIT ratio has moved down 12.9 over the prior 123 months.

Below are key valuation metrics over time for ZTS.

Stock Date P/S P/B P/E EV/EBIT
ZTS 2023-03-17 9.4 17.3 36.1 28.0
ZTS 2023-03-16 9.5 17.5 36.5 28.3
ZTS 2023-03-15 9.4 17.2 35.9 27.9
ZTS 2023-03-14 9.4 17.3 36.1 28.0
ZTS 2023-03-13 9.4 17.2 35.8 27.9
ZTS 2023-03-10 9.3 17.0 35.4 27.6

ZTS Growth Metrics

    The 3 year net income to common stockholders growth rate now stands at 49.35%.
  • Its year over year cash and equivalents growth rate is now at -12.97%.
  • Its year over year net income to common stockholders growth rate is now at 16.85%.
Over the past 34 months, ZTS's revenue has gone up $1,741,000,000.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 8,080 1,912 2,114
2022-09-30 8,007 1,850 2,067
2022-06-30 7,995 1,977 2,090
2022-03-31 7,891 2,122 2,073
2021-12-31 7,776 2,213 2,037
2021-09-30 7,616 2,252 1,982

ZTS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZTS has a Quality Grade of A, ranking ahead of 95.14% of graded US stocks.
  • ZTS's asset turnover comes in at 0.552 -- ranking 69th of 682 Pharmaceutical Products stocks.
  • UTHR, ENDP, and MYGN are the stocks whose asset turnover ratios are most correlated with ZTS.

The table below shows ZTS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.552 0.697 0.236
2021-06-30 0.537 0.695 0.233
2021-03-31 0.518 0.694 0.219
2020-12-31 0.514 0.692 0.206
2020-09-30 0.525 0.696 0.212
2020-06-30 0.535 0.697 0.207

ZTS Price Target

For more insight on analysts targets of ZTS, see our ZTS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $185.00 Average Broker Recommendation 1.34 (Strong Buy)

ZTS Stock Price Chart Interactive Chart >

Price chart for ZTS

ZTS Price/Volume Stats

Current price $164.18 52-week high $201.32
Prev. close $161.24 52-week low $124.15
Day low $159.97 Volume 1,864,800
Day high $164.94 Avg. volume 2,224,075
50-day MA $165.78 Dividend yield 0.93%
200-day MA $160.02 Market Cap 76.08B

Zoetis Inc. (ZTS) Company Bio

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. (Source:Wikipedia)

ZTS Latest News Stream

Event/Time News Detail
Loading, please wait...

ZTS Latest Social Stream

Loading social stream, please wait...

View Full ZTS Social Stream

Latest ZTS News From Around the Web

Below are the latest news stories about ZOETIS INC that investors may wish to consider to help them evaluate ZTS as an investment opportunity.

Zoetis (ZTS) Dips More Than Broader Markets: What You Should Know

Zoetis (ZTS) closed at $164.47 in the latest trading session, marking a -1.11% move from the prior day.

Yahoo | March 17, 2023

The Zacks Analyst Blog Highlights Nike, Salesforce, Zoetis, Archer-Daniels-Midland and Trane Technologies

Nike, Salesforce, Zoetis, Archer-Daniels-Midland and Trane Technologies are part of the Zacks top Analyst Blog.

Yahoo | March 17, 2023

Top Research Reports for Nike, Salesforce & Zoetis

Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), Salesforce, Inc. (CRM) and Zoetis Inc. (ZTS).

Yahoo | March 16, 2023

Zoetis (ZTS) Down 6.5% Since Last Earnings Report: Can It Rebound?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | March 16, 2023

Zoetis Named One of the World’s Most Ethical Companies by Ethisphere

PARSIPPANY, N.J., March 13, 2023--Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies. In 2023, 135 honorees were recognized, spanning 19 countries and 46 industries. Zoetis is one of three pharmaceutical companies and the only standalone animal health company included on the list.

Yahoo | March 13, 2023

Read More 'ZTS' Stories Here

ZTS Price Returns

1-mo -1.29%
3-mo N/A
6-mo 10.39%
1-year -12.63%
3-year 41.97%
5-year 106.98%
YTD 12.29%
2022 -39.51%
2021 48.26%
2020 25.76%
2019 55.71%
2018 19.45%

ZTS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZTS Dividend History

Continue Researching ZTS

Here are a few links from around the web to help you further your research on Zoetis Inc's stock as an investment opportunity:

Zoetis Inc (ZTS) Stock Price | Nasdaq
Zoetis Inc (ZTS) Stock Quote, History and News - Yahoo Finance
Zoetis Inc (ZTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8106 seconds.